Last week’s trading closed with risk-linked assets overperforming safe haven assets, leading to a weekly loss in the US dollar versus gains for gold as well as US stocks over the week, as most risk assets kept surging. An interesting competition was strong between the minutes ff the Fed’s last …
Read More »Nasdaq boosted following Nvidia’s earnings
As Nvidia’s stock surged to an all-time high, the S&P 500 approached a new high and global stock rallies gained momentum.The chip manufacturer, propelled by the surge in demand for AI systems, announced another quarter of record-breaking performance. During afternoon trade, Nvidia’s shares increased by 15%. As a result, the …
Read More »US stocks mixed ahead of weekend
After the market closed on Friday, US equities were mixed, with gains coming from the oil and gas, utilities, and telecoms industries while losses came from the technology, basic materials, and consumer goods industries.The NASDAQ Composite index lost 0.20%, the S&P 500 index lost 0.01%, and the Dow Jones Industrial …
Read More »US equities advance following earliest batch of corporate earnings
Monday’s trading session saw an increase in US stocks as another round of crucial earnings started. Following the fall of Silicon Valley Bank last month, investors are still paying close attention to financial institutions’ earnings. The technology-heavy Nasdaq Composite (IXIC), the S&P 500 (GSPC), and the Dow Jones Industrial Average …
Read More »Wall Street floats through a quiet US session ahead of CPI data
Stocks and bonds made small changes on Wall Street on Tuesday as trading was quiet in anticipation of news later in the week that might affect the markets.The S&P 500 lost 0.17 points, or less than 0.1%, to 4,108.94, its smallest one-day movement in more than a year. The majority …
Read More »Moderna’s earnings rise above expectations
Moderna’s Q2 results have beaten Wall Street’s quarterly earnings and revenue expectations. The Boston-based company generated $4.7 billion in sales for the quarter, a 9% increase over the same period last year.The biotech company’s costs rose to $1.4 billion, or 30% of the revenue generated from its vaccine. Moderna also …
Read More »Moderna is testing a potential monkeypox vaccine
Moderna is testing a potential monkeypox vaccine in preclinical testing as the disease spreads in the United States and Europe. The World Health Organization said on Tuesday that the number of confirmed cases of monkeypox has reached 131 and there are 106 other suspected cases since the first infection was …
Read More »Vaccine Concerns Push Crude Oil Down
Crude oil prices stumbled on Tuesday US crude futures fell by more than 6%, after Moderna’s chief ignited doubts about the efficiency of COVID-19 vaccines against the Omicron variant, startling financial markets and heightening worries about oil demand.Brent crude futures fell $2.95, or 4%, to $70.49 a barrel by 12:12 …
Read More »Improved Mood Pushes The Dollar Higher
Fears retreated on Monday after panic had dominated financial markets for three days when stocks markets collapsed following the news on a new virus variant known as Omicron. However, the market’s reaction may have been worsened by thin market conditions due to the Thanksgiving holiday in the US.Up till Monday, …
Read More »Lockdown News Quakes Wall Street, USD Boosted
Renewed concerns about COVID-19 in the face of looming European lockdowns impacted a range of sectors Friday, pushing stocks and oil down. This latest news boosts the US dollar.Stocks have been shaken in morning trading on Wall Street Friday and major indexes were on track for a mixed finish to …
Read More »